| Research Topics: |
| INDEX |
| AI-chat 4 |
| PRIME 33 |
| aging 7 |
| body 1 |
| brain 9 |
| cancer 10 |
| climate 1 |
| cognition 4 |
| covid-19 4 |
| crime 5 |
| culture 2 |
| dental 2 |
| diabetes 3 |
| diagnostics 1 |
| disease 1 |
| drugs 1 |
| economy 1 |
| election 3 |
| energy 1 |
| eyes 1 |
| gender 1 |
| genetics 4 |
| gut 3 |
| heart 5 |
| immune 4 |
| kidneys 1 |
| language 1 |
| metabolism 3 |
| microbiome 1 |
| misc 1 |
| nutrition 4 |
| obesity 1 |
| pain 1 |
| physical 1 |
| politics 8 |
| pollution 6 |
| privacy 1 |
| psychology 5 |
| quantum 3 |
| reproduction 2 |
| rights 2 |
| sleep 1 |
| soc-media |
| space 2 |
| stress 2 |
| tech 1 |
| unk |
| vaccine 4 |
| virus 3 |
| war-confl |
| war-cyber 4 |
|
Scanned: 2595 Evaluated: 284 Selected: 69 |
| PRIME BODY IMMUNE PAIN PHYSICAL | ||||||||
Sd294-004 | Natural Compound May Fight Rheumatoid Arthritis at Its Source | |||||||
| Quote: | A natural compound called obakulactone (OL) may offer a new way to treat rheumatoid arthritis (RA), according to a study published in Engineering. OL is a tetracyclic triterpenoid isolated from Phellodendri cortex. Researchers found that it reduced signs of arthritis by promoting the breakdown of acyl coenzyme A thioesterase 1 (ACOT1) through the ubiquitin#8210;proteasome pathway and by restoring the balance of unsaturated fatty acids. The findings help explain how OL acts on rheumatoid arthritis at the molecular level. They also identify ACOT1 as a possible new drug target and suggest that correcting disrupted fatty acid metabolism could become a useful strategy for treating RA. | |||||||
| Article: | https://www.sciencedaily.com//releases/2026/07/260721000845.htm | |||||||
| Search Similar: | Brave Mojeek Startpage Dogpile Bing Googl Lycos Utub Yaho | |||||||
|
Javilk's Research Links Newsletter for Week 29 Updated 07/25/2026-03:15:16 AM What interests you? What have you found? Tell me! Drop me a note to subscribe or submit something. |